Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis

• Asıl Yazarlar: Y. M. Spivakovskiy (Yazar), Y. V. Chernenkov (Yazar), A. Y. Spivakovskaya (Yazar), O. V. Skupova (Yazar), E. N. Shulgina (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Union of pediatricians of Russia, 2016-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The article presents a case of using genetically engineered biopharmaceutical tocilizumab in a child with systemic juvenile idiopathic arthritis. On the initial stage, the treatment was characterized by resistance to high doses of glucocorticoids and cytostatic drugs. Successful termination of visce...